Lexology January 23, 2026
Duane Morris LLP

The 2026 Consolidated Appropriations Act, HR 7148, was passed by the U.S. House of Representatives on January 22, 2026. It includes several significant provisions impacting pharmacy benefit managers (PBMs), with one of the most consequential changes being Congress’ directive to the Centers for Medicare and Medicaid Services (CMS) to define and enforce what constitutes “reasonable and relevant” contract terms between Medicare Part D plans (and their PBMs) and pharmacies. These changes have particular importance for the operation and enforcement of “any willing pharmacy” (AWP) requirements.

Medicare Part D includes a statutory AWP requirement designed to promote beneficiary access to pharmacy services. In general terms, AWP requires that a Part D plan permit any pharmacy to participate in the network, so...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety
CVS accused of shutting out rival pharmacy hubs in House Judiciary investigation
Mirum Pharmaceuticals Completes $268.6 Million Acquisition of Bluejay Therapeutics to Strengthen Rare Disease Pipeline
The case for transparent pricing: Making pharmacy benefits work for health plans

Share Article